» Articles » PMID: 30506671

High Tumour Plasma Cell Infiltration Reflects an Important Microenvironmental Component in Classic Hodgkin Lymphoma Linked to Presence of B-symptoms

Overview
Journal Br J Haematol
Specialty Hematology
Date 2018 Dec 4
PMID 30506671
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma cells are important prognostic actors in different malignancies. The tumour microenvironmental composition in classic Hodgkin lymphoma (cHL) is a major prognostic key element; however, clinicopathological studies regarding plasma cells in cHL are lacking. The aim of this study was to investigate CD138+ (also termed SDC1+) plasma cell and IgG4 producing (IgG4+) plasma cells infiltration in the microenvironment of cHL. Immunohistochemistry with anti-CD138 and IgG4 antibodies was performed on diagnostic tumour biopsies from 124 patients with cHL, on tissue micro array (TMA). In 120 cases, CD138+ plasma cell-infiltration was associated with the presence of B-symptoms (P = 0·028) and advanced stage, IIB-IVB (P = 0·009). In multivariate analysis, CD138+ plasma cells correlated with eosinophil infiltration (P = 0·013). The subgroup of IgG4+ plasma cells was analysed in 122 cases and only correlated to CD138+ plasma cells (P = 0·004). Patients with high proportion of tumour infiltrating CD138+ plasma cells (defined as ≥10%), had a more inferior event-free survival (P = 0·007) and overall survival (P = 0·004) than patients with a low proportion of infiltrating CD138+ plasma cells (<10%), although significance was not maintained in multivariate analysis. In summary, a high proportion of tumour-associated plasma cells in cHL reflect an important component in the microenvironment of cHL.

Citing Articles

Tumour-reactive plasma cells in antitumour immunity: current insights and future prospects.

Chen P, Chu Y, Liu R Immunother Adv. 2024; 4(1):ltae003.

PMID: 38736973 PMC: 11088280. DOI: 10.1093/immadv/ltae003.


The role of IgG4-positive plasma cell population in classic Hodgkin lymphoma.

Guler B, Tekden B, Cetin G, Yildiz P, Turna S, Uysal O J Hematop. 2024; 16(4):191-197.

PMID: 38175429 DOI: 10.1007/s12308-023-00559-2.


Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications.

Georgoulis V, Papoudou-Bai A, Makis A, Kanavaros P, Hatzimichael E Biology (Basel). 2023; 12(6).

PMID: 37372147 PMC: 10294989. DOI: 10.3390/biology12060862.


The role of immunohistochemistry in the assessment of classical Hodgkin lymphoma microenvironment.

Lacet D, Oliveira C Int J Clin Exp Pathol. 2022; 15(10):412-424.

PMID: 36381421 PMC: 9638837.


Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma.

Casagrande N, Borghese C, Aldinucci D Cancers (Basel). 2022; 14(10).

PMID: 35626032 PMC: 9139207. DOI: 10.3390/cancers14102427.